Vigene Biosciences Is Now Part of Charles River

Vigene Biosciences

In June 2021, Charles River acquired Vigene Biosciences, a trusted leader in contract development and manufacturing solutions for gene therapy. Vigene, along with other cell and gene therapy CDMO providers, Cobra Biologics and Cognate BioServices, join Charles River to offer customers a single trusted partner who has the insight and experience to take your cell and gene products from bench to bedside.

Connect With a Viral Vector and Plasmid Specialist


Explore Our Cell and Gene Therapy CDMO Solutions

Stay Connected

Stay connected through this exciting transition by joining our mailing list. Sign up to keep in touch with our industry-leading scientists and receive news about our world-class products and services.

Sign up